Cost-effectiveness of PCSK9 Inhibitor Therapy
- PMID: 27893122
- DOI: 10.1001/jama.2016.16286
Cost-effectiveness of PCSK9 Inhibitor Therapy
Comment in
-
Cost-effectiveness of PCSK9 Inhibitor Therapy-Reply.JAMA. 2016 Nov 22;316(20):2152. doi: 10.1001/jama.2016.16292. JAMA. 2016. PMID: 27893125 No abstract available.
Comment on
-
Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease.JAMA. 2016 Aug 16;316(7):743-53. doi: 10.1001/jama.2016.11004. JAMA. 2016. PMID: 27533159
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous